Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer

Clinical trial NCT07025174 · RECRUITING

Trial details

NCT number: NCT07025174
Sponsor: First Affiliated Hospital of Zhejiang University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bile Duct Carcinoma Gall Bladder Cancer Biliary Tract Cancer Cholangiocarcinoma

Start date: 2025-06-01
Primary completion: 2026-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.